Diurnal Characteristics of the Orexin System Genes and Its Effects on Pathology at Early Stage in 3xTg-AD Mice

被引:1
|
作者
Yin, Jing [1 ,2 ,3 ,4 ]
Tuo, Chun-Mei [1 ,2 ,3 ]
Yu, Kai-Yue [1 ,2 ,3 ]
Hu, Xiao-Hong [1 ,2 ,3 ]
Fan, Yan-Ying [4 ]
Wu, Mei-Na [1 ,2 ,3 ]
机构
[1] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China
[2] Minist Educ, Key Lab Cellular Physiol, Taiyuan, Shanxi, Peoples R China
[3] Shanxi Med Univ, Key Lab Cellular Physiol Shanxi Prov, Taiyuan, Shanxi, Peoples R China
[4] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Shanxi, Peoples R China
关键词
Alzheimer's disease; Orexin; Circadian rhythm; Beta-site amyloid precursor protein cleaving enzyme; Core clock genes; CEREBROSPINAL-FLUID LEVELS; ALZHEIMERS-DISEASE; SLEEP; IMPAIRMENT; MODEL; DISRUPTION; EXPRESSION; RECEPTORS; RHYTHMS; BETA;
D O I
10.1007/s12017-023-08767-w
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Orexin and its receptors are closely related to the pathogenesis of Alzheimer's disease (AD). Although the expression of orexin system genes under physiological condition has circadian rhythm, the diurnal characteristics of orexin system genes, and its potential role in the pathogenesis in AD are unknown. In the present study, we hope to elucidate the diurnal characteristics of orexin system genes at the early stage of AD, and to investigate its potential role in the development of AD neuropathology. We firstly detected the mRNA levels of orexin system genes, AD risk genes and core clock genes (CCGs) in hypothalamus and hippocampus in 6-month-old male 3xTg-AD mice and C57BL/6J (wild type, WT) control mice, then analyzed diurnal expression profiles of all genes using JTK_CYCLE algorithm, and did the correlation analysis between expression of orexin system genes and AD risk genes or CCGs. In addition, the expression of beta-amyloid protein (A beta) and phosphorylated tau (p-tau) protein were measured. The results showed that the diurnal mRNA expression profiles of PPO, OX1R, OX2R, Bace2, Bmal1, Per1, Per2 and Cry1 in the hypothalamus, and gene expression of OX1R, OX2R, Bace1, Bmal1, Per1 and Cry2 in the hippocampus in 3xTg-AD mice were different from that in WT mice. Furthermore, there is positive correlation between orexin system genes and AD risk genes or CCGs in the brain in 3xTg-AD mice. In addition, the expression of A beta and p-tau in hippocampus in 3xTg-AD mice were significantly increased, and the expression of p-tau is higher in night than in day. These results indicate that the abnormal expression profiles of orexin system genes and its interaction with AD risk genes or CCGs might exert important role in the pathogenesis of AD, which will increase the expression of A beta and p-tau, and accelerate the development of AD.
引用
收藏
页码:632 / 643
页数:12
相关论文
共 50 条
  • [31] Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid ,B metabolism
    Li, Yi-Ying
    Yu, Kai-Yue
    Cui, Yu-Jia
    Wang, Zhao-Jun
    Cai, Hong-Yan
    Cao, Ji-Min
    Wu, Mei-Na
    NEUROBIOLOGY OF AGING, 2023, 124 : 71 - 84
  • [32] Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of alzheimer disease
    Gimenez-Llort, Lydia
    Rivera-Hernandez, Geovanny
    Marin-Argany, Marta
    Sanchez-Quesada, Jose L.
    Villegas, Sandra
    MABS, 2013, 5 (05) : 665 - 677
  • [33] Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice
    Montoliu-Gaya, Laia
    Guell-Bosch, Jofre
    Esquerda-Canals, Gisela
    Roda, Alejandro R.
    Serra-Mir, Gabriel
    Lope-Piedrafita, Silvia
    Luis Sanchez-Quesada, Jose
    Villegas, Sandra
    BIOCHEMICAL PHARMACOLOGY, 2018, 155 : 380 - 392
  • [34] Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice
    Fertan, Emre
    Stover, Kurt R. J.
    Brant, Michael G.
    Stafford, Paul M.
    Kelly, Brendan
    Diez-Cecilia, Elena
    Wong, Aimee A.
    Weaver, Donald F.
    Brown, Richard E.
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] Aging Reduces Estradiol Protection Against Neural but Not Metabolic Effects of Obesity in Female 3xTg-AD Mice
    Christensen, Amy
    Liu, Jiahui
    Pike, Christian J.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [36] Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease
    Mori, Hiroaki
    Yoshino, Yuta
    Iga, Jun-ichi
    Ochi, Shinichiro
    Funahashi, Yu
    Yamazaki, Kiyohiro
    Kumon, Hiroshi
    Ozaki, Yuki
    Ueno, Shu-ichi
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (01) : 177 - 188
  • [37] Diffusion MRI detects early brain microstructure abnormalities in 2-month-old 3xTg-AD mice
    Falangola, Maria Fatima
    Nie, Xingju
    Ward, Ralph
    McKinnon, Emilie T.
    Dhiman, Siddhartha
    Nietert, Paul J.
    Helpern, Joseph A.
    Jensen, Jens H.
    NMR IN BIOMEDICINE, 2020, 33 (09)
  • [38] Short-term modern life-like stress exacerbates A-pathology and synapse loss in 3xTg-AD mice
    Baglietto-Vargas, David
    Chen, Yuncai
    Suh, Dongjin
    Ager, Rahasson R.
    Rodriguez-Ortiz, Carlos J.
    Medeiros, Rodrigo
    Myczek, Kristoffer
    Green, Kim N.
    Baram, Tallie Z.
    LaFerla, Frank M.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 (05) : 915 - 926
  • [39] Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice
    Bitto, Alessandra
    Giuliani, Daniela
    Pallio, Giovanni
    Irrera, Natasha
    Vandini, Eleonora
    Canalini, Fabrizio
    Zaffe, Davide
    Ottani, Alessandra
    Minutoli, Letteria
    Rinaldi, Mariagrazia
    Guarini, Salvatore
    Squadrito, Francesco
    Altavilla, Domenica
    INFLAMMATION RESEARCH, 2017, 66 (05) : 389 - 398
  • [40] Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice
    Alessandra Bitto
    Daniela Giuliani
    Giovanni Pallio
    Natasha Irrera
    Eleonora Vandini
    Fabrizio Canalini
    Davide Zaffe
    Alessandra Ottani
    Letteria Minutoli
    Mariagrazia Rinaldi
    Salvatore Guarini
    Francesco Squadrito
    Domenica Altavilla
    Inflammation Research, 2017, 66 : 389 - 398